1. Home
  2. FFIN vs BLCO Comparison

FFIN vs BLCO Comparison

Compare FFIN & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Financial Bankshares Inc.

FFIN

First Financial Bankshares Inc.

HOLD

Current Price

$35.25

Market Cap

4.9B

Sector

Finance

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.30

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFIN
BLCO
Founded
1890
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Ophthalmic Goods
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
5.4B
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
FFIN
BLCO
Price
$35.25
$16.30
Analyst Decision
Hold
Buy
Analyst Count
2
11
Target Price
$36.50
$18.45
AVG Volume (30 Days)
896.0K
340.4K
Earning Date
04-16-2026
04-29-2026
Dividend Yield
2.39%
N/A
EPS Growth
13.46
N/A
EPS
0.50
N/A
Revenue
N/A
$5,101,000,000.00
Revenue This Year
$17.16
$8.65
Revenue Next Year
$6.61
$5.59
P/E Ratio
$72.96
N/A
Revenue Growth
N/A
6.47
52 Week Low
$28.12
$13.09
52 Week High
$38.13
$18.92

Technical Indicators

Market Signals
Indicator
FFIN
BLCO
Relative Strength Index (RSI) 56.93 51.42
Support Level $31.30 $15.36
Resistance Level $35.77 $16.54
Average True Range (ATR) 0.76 0.48
MACD 0.04 -0.03
Stochastic Oscillator 49.62 23.23

Price Performance

Historical Comparison
FFIN
BLCO

About FFIN First Financial Bankshares Inc.

First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: